User contributions for Alara E. Dagsali

30 April 2024

• 18:1518:15, 30 April 2024 diff hist +3 Botulism Antitoxin No edit summary current
• 18:1418:14, 30 April 2024 diff hist +18,008 N Botulism Antitoxin Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=BAT |aOrAn=a |indicationType=treatment |indication=BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients. |adverseReactions=The most common adverse reactions obse..."

29 April 2024

• 15:2615:26, 29 April 2024 diff hist +27 User:AED No edit summary
• 15:2515:25, 29 April 2024 diff hist −35 Trastuzumab emtansine No edit summary current
• 15:2315:23, 29 April 2024 diff hist +40,610 N Trastuzumab emtansine Created page with "{{DrugProjectFormSinglePage |authorTag=AlaraE.Dagsali |genericName=ado-trastuzumab emtansine |indicationType=treatment |indication=the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either: received prior therapy for metastatic disease, or developed disease recurrence during or within six months of completing adjuvant therapy. the adjuvant treatment..."

25 April 2024

• 22:5322:53, 25 April 2024 diff hist −3 Reni Syndrome No edit summary current
• 22:5222:52, 25 April 2024 diff hist −144 User:AED No edit summary
• 22:5122:51, 25 April 2024 diff hist +407 User:AED No edit summary
• 22:4822:48, 25 April 2024 diff hist +3 Adagrasib No edit summary current
• 22:4822:48, 25 April 2024 diff hist +20 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) No edit summary current
• 22:4522:45, 25 April 2024 diff hist +3 Norelgestromin No edit summary current
• 22:4522:45, 25 April 2024 diff hist +11 Tranexamic No edit summary current
• 22:4422:44, 25 April 2024 diff hist −11 Tranexamic No edit summary
• 22:4122:41, 25 April 2024 diff hist +2 Tranexamic No edit summary
• 22:4122:41, 25 April 2024 diff hist −1 Tranexamic No edit summary
• 22:4022:40, 25 April 2024 diff hist +14 Tranexamic No edit summary Tag: Manual revert
• 22:3922:39, 25 April 2024 diff hist −14 Tranexamic No edit summary Tag: Manual revert
• 22:3922:39, 25 April 2024 diff hist +2,941 N User:AED Created page with "==Alara Ece Dagsali== '''Alara Ece Dagsali''' <br>'''Contact:''' email: alaraecedagsai99@gmail.com; +905313614710 ==Medical Education== *School of Medicine (M.D.): Istanbul Medipol University 2021- 2024 Demiroglu Bilim University 2018-2021 ==Pages authored/Co-authored/Collaborated== ===2023=== ====Authored:==== *Reni Syndrome ==Work Experience== *Wikidoc - Associate Editor-In-Chief, 2023 - Current *Yeditepe University Hospitals Cardiac Electrophysiology Lab, Ista..."
• 22:3622:36, 25 April 2024 diff hist +40 Alara E. Dagsali No edit summary

24 April 2024

• 21:2621:26, 24 April 2024 diff hist +14 Tranexamic No edit summary Tag: Manual revert
• 21:2621:26, 24 April 2024 diff hist −11 Tranexamic No edit summary
• 21:2521:25, 24 April 2024 diff hist −14 Template:AlaraE.Dagsali No edit summary current
• 21:2521:25, 24 April 2024 diff hist −2 Tranexamic No edit summary Tag: Manual revert
• 21:2321:23, 24 April 2024 diff hist −1 Tranexamic No edit summary
• 21:2321:23, 24 April 2024 diff hist +3 Tranexamic No edit summary Tag: Visual edit: Switched
• 21:2221:22, 24 April 2024 diff hist −1 Tranexamic No edit summary
• 21:2121:21, 24 April 2024 diff hist +88 N Template:AlaraE.Dagsali Created page with " Alara Ece Dagsali, M.D.[mailto:alaraecedagsali99@gmail.com]"
• 21:1421:14, 24 April 2024 diff hist +23,020 N Tranexamic Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=Tranexamic |aOrAn=a |drugClass=hemophilia drug |indicationType=prevention |indication=Tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. |adverseReactions=Thromboembolic Risk Seizures Hypersensitivity Reactions Visual Disturbances Dizzines..."

22 April 2024

• 18:4418:44, 22 April 2024 diff hist 0 N File:D2f97c72-bbfb-426e-b742-6e25234ba1ff 2.jpg No edit summary current
• 18:4318:43, 22 April 2024 diff hist 0 N File:Ae8d4ea7-c895-403b-a435-56dc4996a3b0.JPG No edit summary current

21 March 2024

• 16:5516:55, 21 March 2024 diff hist +43 Norelgestromin No edit summary
• 16:5316:53, 21 March 2024 diff hist +12,388 Norelgestromin No edit summary
• 16:2816:28, 21 March 2024 diff hist +22,456 Norelgestromin No edit summary
• 08:4608:46, 21 March 2024 diff hist +1,580 Norelgestromin No edit summary
• 08:3508:35, 21 March 2024 diff hist +929 Norelgestromin No edit summary
• 08:3308:33, 21 March 2024 diff hist +3,183 N Norelgestromin Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=NORELGESTROMIN AND ETHINLY ESTRADIOL patch |indicationType=prevention |indication=Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m for whom a combined hormonal contraceptive is appropriate. |hasBlackBoxWarning=Yes |adverseReactions=The following serious adverse reactions with the use of co..."

15 February 2024

• 02:0902:09, 15 February 2024 diff hist +1,330 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) No edit summary
• 02:0102:01, 15 February 2024 diff hist 0 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) No edit summary
• 02:0002:00, 15 February 2024 diff hist −40,428 Coronary heart disease in Diabetics Replaced content with "__NOTOC__ {{ADA guidelines}} {{CMG}} {{AE}} {{SCh}}; {{MehdiP}}; {{TarekNafee}} ==2016 ADA Standards of Medical Care in Diabetes Guidelines<ref name="urlcare.diabetesjournals.org">{{cite web |url=http://care.diabetesjournals.org/content/suppl/2015/12/21/39.Supplement_1.DC2/2016-Standards-of-Care.pdf |title=care.diabetesjournals.org |format= |work= |accessdate=}}</ref>== ===Screening=== {|class="wikitable" | bgcolor="Seashell"|<nowiki>"</nowiki>'''1.'''In asymptomatic..." current Tag: Replaced
• 02:0002:00, 15 February 2024 diff hist +40,625 N 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) Created page with "{{ADA guidelines}} {{CMG}} {{AE}} {{SCh}}; {{MehdiP}}; {{TarekNafee}} ==2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines f..."
• 01:5501:55, 15 February 2024 diff hist +1,959 Coronary heart disease in Diabetics No edit summary
• 01:5301:53, 15 February 2024 diff hist +958 Coronary heart disease in Diabetics No edit summary
• 01:4801:48, 15 February 2024 diff hist +5,725 Coronary heart disease in Diabetics No edit summary
• 01:3801:38, 15 February 2024 diff hist +2 Coronary heart disease in Diabetics No edit summary
• 01:3301:33, 15 February 2024 diff hist 0 Coronary heart disease in Diabetics No edit summary
• 01:3201:32, 15 February 2024 diff hist −4 Coronary heart disease in Diabetics No edit summary
• 01:1601:16, 15 February 2024 diff hist +1 Coronary heart disease in Diabetics No edit summary
• 01:1401:14, 15 February 2024 diff hist +3,056 Coronary heart disease in Diabetics No edit summary
• 01:0701:07, 15 February 2024 diff hist −45 Coronary heart disease in Diabetics No edit summary
• 01:0401:04, 15 February 2024 diff hist +2,663 Coronary heart disease in Diabetics No edit summary